
Malgorzata A. Walicka
Examiner (ID: 315)
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1652 |
| Total Applications | 345 |
| Issued Applications | 187 |
| Pending Applications | 28 |
| Abandoned Applications | 130 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17148334
[patent_doc_number] => 11141385
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-12
[patent_title] => Sulfur (VI) fluoride compounds and methods for the preparation thereof
[patent_app_type] => utility
[patent_app_number] => 17/012783
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 37
[patent_no_of_words] => 43294
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 199
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17012783
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/012783 | Sulfur (VI) fluoride compounds and methods for the preparation thereof | Sep 3, 2020 | Issued |
Array
(
[id] => 17913153
[patent_doc_number] => 20220315548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/638929
[patent_app_country] => US
[patent_app_date] => 2020-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35516
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638929
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/638929 | SMALL MOLECULE AGONISTS OF MUCOLIPIN 1 AND USES THEREOF | Aug 27, 2020 | Abandoned |
Array
(
[id] => 16613633
[patent_doc_number] => 20210032286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => PSMA Imaging Agents
[patent_app_type] => utility
[patent_app_number] => 16/999541
[patent_app_country] => US
[patent_app_date] => 2020-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16999541
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/999541 | PSMA Imaging Agents | Aug 20, 2020 | Pending |
Array
(
[id] => 19521142
[patent_doc_number] => 12122851
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-22
[patent_title] => PSMA imaging agents
[patent_app_type] => utility
[patent_app_number] => 16/999576
[patent_app_country] => US
[patent_app_date] => 2020-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 13
[patent_no_of_words] => 40710
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16999576
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/999576 | PSMA imaging agents | Aug 20, 2020 | Issued |
Array
(
[id] => 16613633
[patent_doc_number] => 20210032286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => PSMA Imaging Agents
[patent_app_type] => utility
[patent_app_number] => 16/999541
[patent_app_country] => US
[patent_app_date] => 2020-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16999541
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/999541 | PSMA Imaging Agents | Aug 20, 2020 | Pending |
Array
(
[id] => 19564792
[patent_doc_number] => 12139554
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-12
[patent_title] => PSMA imaging agents
[patent_app_type] => utility
[patent_app_number] => 16/999563
[patent_app_country] => US
[patent_app_date] => 2020-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 13
[patent_no_of_words] => 40638
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16999563
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/999563 | PSMA imaging agents | Aug 20, 2020 | Issued |
Array
(
[id] => 16720006
[patent_doc_number] => 20210087153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-25
[patent_title] => SMALL MOLECULES AND METHODS OF REDUCING INJURIES CAUSED BY RADIATION OR CHEMICALS
[patent_app_type] => utility
[patent_app_number] => 16/992681
[patent_app_country] => US
[patent_app_date] => 2020-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4304
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16992681
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/992681 | Small molecules and methods of reducing injuries caused by radiation or chemicals | Aug 12, 2020 | Issued |
Array
(
[id] => 16770780
[patent_doc_number] => 10981868
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-04-20
[patent_title] => Single step regioselective cyclization and chlorination of hydroxyamino-N-(2-methylphenyl)acetamide to 5-chloro-7-methylindoline-2,3-dione
[patent_app_type] => utility
[patent_app_number] => 16/992034
[patent_app_country] => US
[patent_app_date] => 2020-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1426
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16992034
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/992034 | Single step regioselective cyclization and chlorination of hydroxyamino-N-(2-methylphenyl)acetamide to 5-chloro-7-methylindoline-2,3-dione | Aug 11, 2020 | Issued |
Array
(
[id] => 17953449
[patent_doc_number] => 11479540
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => Nonpeptide somatostatin type 5 receptor agonists and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/989193
[patent_app_country] => US
[patent_app_date] => 2020-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46472
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 496
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16989193
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/989193 | Nonpeptide somatostatin type 5 receptor agonists and uses thereof | Aug 9, 2020 | Issued |
Array
(
[id] => 17866948
[patent_doc_number] => 20220289683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => PROCESS-SCALE SYNTHESIS OF A PLASMA KALLIKREIN INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/632585
[patent_app_country] => US
[patent_app_date] => 2020-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11400
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17632585
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/632585 | Process-scale synthesis of a plasma kallikrein inhibitor | Aug 4, 2020 | Issued |
Array
(
[id] => 17852239
[patent_doc_number] => 20220282281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => COMPOSITIONS FOR TRANSFECTING A NUCLEIC ACID MOLECULE INTO A CELL COMPRISING TRIAZOLE COMPOUNDS GRAFTED TO A CATIONIC POLYMER, AND THEIR APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/633060
[patent_app_country] => US
[patent_app_date] => 2020-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16911
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 382
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17633060
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/633060 | COMPOSITIONS FOR TRANSFECTING A NUCLEIC ACID MOLECULE INTO A CELL COMPRISING TRIAZOLE COMPOUNDS GRAFTED TO A CATIONIC POLYMER, AND THEIR APPLICATIONS | Aug 4, 2020 | Pending |
Array
(
[id] => 18162708
[patent_doc_number] => 20230029301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => SCALEABLE PREPARATION OF POLYKETIDES
[patent_app_type] => utility
[patent_app_number] => 17/632764
[patent_app_country] => US
[patent_app_date] => 2020-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56374
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17632764
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/632764 | SCALEABLE PREPARATION OF POLYKETIDES | Aug 4, 2020 | Pending |
Array
(
[id] => 17944304
[patent_doc_number] => 20220331321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => ANTIMALARIAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/633655
[patent_app_country] => US
[patent_app_date] => 2020-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17633655
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/633655 | Antimalarial agents | Jul 20, 2020 | Issued |
Array
(
[id] => 17944304
[patent_doc_number] => 20220331321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => ANTIMALARIAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/633655
[patent_app_country] => US
[patent_app_date] => 2020-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17633655
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/633655 | Antimalarial agents | Jul 20, 2020 | Issued |
Array
(
[id] => 16727983
[patent_doc_number] => 20210095130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => ULTRA BRIGHT DIMERIC OR POLYMERIC DYES AND METHODS FOR PREPARATION OF THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/934912
[patent_app_country] => US
[patent_app_date] => 2020-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17918
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16934912
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/934912 | ULTRA BRIGHT DIMERIC OR POLYMERIC DYES AND METHODS FOR PREPARATION OF THE SAME | Jul 20, 2020 | Abandoned |
Array
(
[id] => 18886353
[patent_doc_number] => 11865109
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-09
[patent_title] => Formulations of (S)-3-amino-6-methoxy-N-(3,3,3-trifluoro-2-hydroxy-2-methylpropyl)-5-(trifluoromethyl)picolinamide
[patent_app_type] => utility
[patent_app_number] => 16/929472
[patent_app_country] => US
[patent_app_date] => 2020-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 24493
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16929472
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/929472 | Formulations of (S)-3-amino-6-methoxy-N-(3,3,3-trifluoro-2-hydroxy-2-methylpropyl)-5-(trifluoromethyl)picolinamide | Jul 14, 2020 | Issued |
Array
(
[id] => 16398692
[patent_doc_number] => 20200339550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => SUBSTITUTED NITROGEN CONTAINING COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/928079
[patent_app_country] => US
[patent_app_date] => 2020-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 100066
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 777
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16928079
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/928079 | SUBSTITUTED NITROGEN CONTAINING COMPOUNDS | Jul 13, 2020 | Abandoned |
Array
(
[id] => 17929681
[patent_doc_number] => 20220324806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => CANNABINOID DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/626516
[patent_app_country] => US
[patent_app_date] => 2020-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34633
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17626516
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/626516 | Cannabinoid derivatives | Jul 9, 2020 | Issued |
Array
(
[id] => 16390924
[patent_doc_number] => 20200331865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => PERK INHIBITORS AND USES THEREOF IN TREATING DISEASES ASSOCIATED WITH AGGREGATION-PRONE PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/920710
[patent_app_country] => US
[patent_app_date] => 2020-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15224
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16920710
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/920710 | PERK inhibitors and uses thereof in treating diseases associated with aggregation-prone proteins | Jul 4, 2020 | Issued |
Array
(
[id] => 18070534
[patent_doc_number] => 11529350
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-20
[patent_title] => Tyrosine kinase non-receptor 1 (TNK1) inhibitors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/919853
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 52688
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16919853
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/919853 | Tyrosine kinase non-receptor 1 (TNK1) inhibitors and uses thereof | Jul 1, 2020 | Issued |